Febuxostat
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB04854 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 9 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypouricemia, renal | KG + DL |
| 2 | hypoxanthine guanine phosphoribosyltransferase partial deficiency | KG + DL |
| 3 | Lesch-Nyhan syndrome | KG + DL |
| 4 | hepatoportal sclerosis | KG + DL |
| 5 | idiopathic copper-associated cirrhosis | KG + DL |
| 6 | hepatopulmonary syndrome | KG + DL |
| 7 | primitive portal vein thrombosis | KG + DL |
| 8 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 9 | hepatic porphyria | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.